These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33099310)

  • 1. Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report.
    Pedicelli S; de Palma L; Pelosini C; Cappa M
    Ital J Pediatr; 2020 Oct; 46(1):158. PubMed ID: 33099310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin.
    Lebastchi J; Ajluni N; Neidert A; Oral EA
    J Clin Endocrinol Metab; 2015 Nov; 100(11):3967-70. PubMed ID: 26390101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celia's encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant.
    Sánchez-Iglesias S; Crocker M; O'Callaghan M; Darling A; García-Cazorla A; Domingo-Jiménez R; Castro A; Fernández-Pombo A; Ruibal Á; Aguiar P; Garrido-Pumar M; Rodríguez-Núñez A; Álvarez-Escudero J; Brown RJ; Araújo-Vilar D
    Neurogenetics; 2019 May; 20(2):73-82. PubMed ID: 30903322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the
    Özalkak Ş; Demiral M; Ünal E; Taş FF; Onay H; Demirbilek H; Özbek MN
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):329-333. PubMed ID: 35735786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berardinelli-Seip syndrome and progressive myoclonus epilepsy.
    Serino D; Davico C; Specchio N; Marras CE; Fioretto F
    Epileptic Disord; 2019 Feb; 21(1):117-121. PubMed ID: 30767895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of metreleptin treatment and dietary intervention with neurological outcomes in Celia's encephalopathy.
    Araújo-Vilar D; Domingo-Jiménez R; Ruibal Á; Aguiar P; Ibáñez-Micó S; Garrido-Pumar M; Martínez-Olmos MÁ; López-Soler C; Guillín-Amarelle C; González-Rodríguez M; Rodríguez-Núñez A; Álvarez-Escudero J; Liñares-Paz M; González-Méndez B; Rodríguez-García S; Sánchez-Iglesias S
    Eur J Hum Genet; 2018 Mar; 26(3):396-406. PubMed ID: 29367704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of long-term metreleptin treatment in patients with lipodystrophy.
    Chan JL; Lutz K; Cochran E; Huang W; Peters Y; Weyer C; Gorden P
    Endocr Pract; 2011; 17(6):922-32. PubMed ID: 22068254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.
    Diker-Cohen T; Cochran E; Gorden P; Brown RJ
    J Clin Endocrinol Metab; 2015 May; 100(5):1802-10. PubMed ID: 25734254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience.
    Araujo-Vilar D; Sánchez-Iglesias S; Guillín-Amarelle C; Castro A; Lage M; Pazos M; Rial JM; Blasco J; Guillén-Navarro E; Domingo-Jiménez R; del Campo MR; González-Méndez B; Casanueva FF
    Endocrine; 2015 May; 49(1):139-47. PubMed ID: 25367549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
    Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
    Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
    Brown RJ; Meehan CA; Cochran E; Rother KI; Kleiner DE; Walter M; Gorden P
    J Clin Endocrinol Metab; 2017 May; 102(5):1511-1519. PubMed ID: 28324110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
    Akinci G; Akinci B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.
    Nagayama A; Ashida K; Watanabe M; Moritaka K; Sonezaki A; Kitajima Y; Takahashi H; Yoshinobu S; Iwata S; Yasuda J; Hasuzawa N; Ozono S; Motomura S; Nomura M
    Front Endocrinol (Lausanne); 2021; 12():690996. PubMed ID: 34135866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin replacement therapy in the management of lipodystrophy syndromes.
    Vigouroux C; Mosbah H; Vatier C
    Ann Endocrinol (Paris); 2024 Jun; 85(3):201-204. PubMed ID: 38871500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
    Meehan CA; Cochran E; Kassai A; Brown RJ; Gorden P
    Expert Rev Clin Pharmacol; 2016; 9(1):59-68. PubMed ID: 26465174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in the treatment of generalized lipodystrophy: role of metreleptin.
    Rodriguez AJ; Mastronardi CA; Paz-Filho GJ
    Ther Clin Risk Manag; 2015; 11():1391-400. PubMed ID: 26396524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome.
    Ferranti S; Lo Rizzo C; Renieri A; Galluzzi P; Grosso S
    Neurol Sci; 2020 Nov; 41(11):3345-3348. PubMed ID: 32440981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.
    Brown RJ; Oral EA; Cochran E; Araújo-Vilar D; Savage DB; Long A; Fine G; Salinardi T; Gorden P
    Endocrine; 2018 Jun; 60(3):479-489. PubMed ID: 29644599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of a child with congenital generalized lipodystrophy accompanied with progressive myoclonic epilepsy: A case report.
    Zhang Y; Chen X; Luo F; Jiang L; Xu J; Chen S
    Medicine (Baltimore); 2019 Nov; 98(48):e18121. PubMed ID: 31770241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.
    Vatier C; Fetita S; Boudou P; Tchankou C; Deville L; Riveline J; Young J; Mathivon L; Travert F; Morin D; Cahen J; Lascols O; Andreelli F; Reznik Y; Mongeois E; Madelaine I; Vantyghem M; Gautier J; Vigouroux C
    Diabetes Obes Metab; 2016 Jul; 18(7):693-7. PubMed ID: 26584826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.